According to Yahoo!Finance, “PAVmed Inc. (PAVM) operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.”
The Study of Failure
“He cited bad management, failure to learn from the lessons of the past, highly-geared buy-outs, and buying assets at too high a price as major reasons for failure. ("Failures among firms grow." Guardian [London, England], 24 Oct. 1990, p. 20. Infotrac Newsstand, Accessed 17 Dec. 2018.).”